FONAR Corporation
NASDAQ:FONRMedical - Devices
+$0.00 today
- Market cap
- $117.76M
- Beta
- 0.95
- P/E (TTM)
- 17.6
- EPS (TTM)
- $1.08
Volume 0.00M
Average 0.08M
FONR Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
FONAR CorporationNASDAQ: FONR
Other Current Liabilities · Q3 FY2026 · quarter ended Mar 2026
Other current liabilities rises 52.3% from a year ago
Other current liabilities stood at $2.32M at the end of Q3 FY2026, up 52.3% from a year earlier and up 73.1% from the prior quarter. Over 3 fiscal years it compounded at +20.7% a year.
Context
- Other current liabilities amounted to 1.1% of total assets at the end of Q3 FY2026, up 0.4 pp from a year earlier.
- Other current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether other current liabilities keeps rising in the next quarterly balance sheet after a +52.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 1.89M USD
- Year-over-year change
- +17.9%
- 4-year CAGR
- +18.9%
| Period | Period end | Other Current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 1.89M | +17.9% |
| FY2024 | 2024-06-30 | 1.6M | +103.8% |
| FY2023 | 2023-06-30 | 785.75K | -26.9% |
| FY2022 | 2022-06-30 | 1.07M | +14.0% |
| FY2021 | 2021-06-30 | 943.24K | — |
Other Current Liabilities vs competitors
How FONR compares with its peers on the latest reported figures
- Peers report in different currencies, so other current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +52.3% is the 3rd highest of 8, against a peer median of +36.3%.
- Other current liabilities amounts to 1.1% of total assets for FONR, versus a peer median of 2.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $13.31M USD | +124.4% | +178.1% | 25.8% | |
| Mar 2026 | €10.13M EUR | +36.3% | — | 20.7% | |
| Mar 2026 | $3.84M USD | -18.8% | — | 6.1% | |
| Mar 2026 | $2.89M USD | -2.5% | +0.0% | 2.4% | |
ARTVArtiva Biotherapeutics, Inc. | Mar 2026 | $2.38M USD | +3154.8% | — | 2.2% |
| Mar 2026 | $2.32M USD | +52.3% | +20.7% | 1.1% | |
| Mar 2026 | $1.28M USD | +44.9% | -8.1% | 2.1% | |
| Mar 2026 | $349K USD | -0.3% | -1.8% | 0.8% | |
| Peer median (excluding FONR) | — | +36.3% | -0.9% | 2.4% | |
Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 44.46M | 48.72M | 51.28M | 56.34M | 56.33M |
| Short-term Investments | 32.18K | 32.33K | 32.8K | 136.1K | 120.49K |
| Net Receivables | 61.2M | 66.47M | 70.17M | 79.85M | 82.94M |
| Inventory | 1.66M | 2.36M | 2.57M | 2.72M | 2.81M |
| Other Current Assets | 0 | 0 | 0 | 1.29M | 2.46M |
| Total Current Assets | 108.58M | 118.69M | 125.66M | 140.32M | 144.67M |
| Property, Plant & Equipment (Net) | 53.11M | 57.44M | 55.94M | 57.67M | 54.04M |
| Goodwill | 4.27M | 4.27M | 4.27M | 4.27M | 4.27M |
| Intangible Assets | 4.04M | 3.7M | 3.43M | 2.87M | 2.99M |
| Long-term Investments | 0 | 1.87M | 710.09K | 0 | 0 |
| Tax Assets | 15.96M | 12.84M | 10.04M | 7.22M | 6.35M |
| Other Non-current Assets | 3.55M | 526.27K | 523.51K | 1.89M | 4.58M |
| Total Non-current Assets | 80.92M | 80.66M | 74.92M | 73.92M | 72.24M |
| Total Assets | 189.51M | 199.34M | 200.58M | 214.25M | 216.91M |
| Account Payables | 1.87M | 1.55M | 1.58M | 1.86M | 1.3M |
| Short-term Debt | 173.21K | 40.08K | 43.77K | 47K | 0 |
| Tax Payables | 1.42M | 630.7K | 241.39K | 1.66M | 640.32K |
| Deferred Revenue | 5.11M | 4.65M | 4.43M | 4.31M | 5.22M |
| Other Current Liabilities | 943.24K | 1.07M | 785.75K | 1.6M | 1.89M |
| Total Current Liabilities | 20.05M | 16.75M | 15.62M | 17.86M | 17.12M |
| Long-term Debt | 760.25K | 155.38K | 115.08K | 66.94K | 0 |
| Deferred Tax Liabilities | 238.32K | 215.73K | 394.76K | 371.56K | 321.16K |
| Deferred Revenue (Non-current) | 2.8M | 1.86M | 760.24K | 1.17M | 3.8M |
| Other Non-current Liabilities | 263.99K | 199.2K | 134.41K | 124.69K | 265.52K |
| Total Non-current Liabilities | 34.09M | 36.36M | 34.13M | 39.6M | 39.68M |
| Total Liabilities | 54.14M | 53.11M | 49.75M | 57.46M | 56.8M |
| Common Stock | 695 | 695 | 685 | 673 | 660 |
| Retained Earnings | (46.01M) | (33.57M) | (24.19M) | (13.62M) | (5.29M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | (3.05M) | (4.05M) | (7.08M) | (9.18M) | (12.5M) |
| Total Equity | 135.37M | 146.24M | 150.83M | 156.79M | 160.1M |
| Total Debt | 34.69M | 38.22M | 37.01M | 41.68M | 38.92M |
| Net Debt | (9.77M) | (10.51M) | (14.27M) | (14.67M) | (17.42M) |
FONAR Corporation
NASDAQ:FONR
Intrinsic Alpha fair value
Locked
Current Price
$19.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.